Page last updated: 2024-10-30

mesoridazine and Basal Ganglia Diseases

mesoridazine has been researched along with Basal Ganglia Diseases in 2 studies

Mesoridazine: A phenothiazine antipsychotic with effects similar to CHLORPROMAZINE.
mesoridazine : A phenothiazine substituted at position 2 (para to the S atom) by a methylsulfinyl group, and on the nitrogen by a 2-(1-methylpiperidin-2-yl)ethyl group.

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Swett, C1
Marcotte, DB1

Other Studies

2 other studies available for mesoridazine and Basal Ganglia Diseases

ArticleYear
Drug-induced dystonia.
    The American journal of psychiatry, 1975, Volume: 132, Issue:5

    Topics: Adjustment Disorders; Adult; Basal Ganglia Diseases; Chlorpromazine; Chlorprothixene; Female; Fluphe

1975
Neuroleptics and neurologic reactions.
    Southern medical journal, 1973, Volume: 66, Issue:3

    Topics: Adolescent; Adult; Antipsychotic Agents; Athetosis; Basal Ganglia Diseases; Female; Humans; Mesorida

1973